Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2022 Results: May 10, 2022
Haemonetics Corporation (NYSE: HAE) will publish its fourth quarter and fiscal year 2022 financial results on May 10, 2022, at 6:00 am EDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics Corporation (NYSE: HAE) will publish its fourth quarter and fiscal year 2022 financial results on May 10, 2022, at 6:00 am EDT. An investor conference call for discussing these results will be held at 8:00 am EDT on the same day. Investors can access the call by dialing (877) 848-8880 for U.S. and Canada or (716) 335-9512 internationally, with Conference ID 5347317. A live webcast will also be available through Haemonetics' investor relations website, with a replay accessible for one year post-call.
Details
News Market Reaction – HAE
The recorded move for HAE in the trading session of this news was -0.07%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, April 6, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter fiscal year 2022 financial results at 6:00 am EDT on Tuesday, May 10, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on May 10, 2022.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512 Conference ID required for access: 5347317
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/gooqch6s
A replay of the conference call and webcast will be available for one year beginning on May 10, 2022 at 11:00 a.m. EDT using the conference call webcast link provided in this press release.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contact:
Olga Guyette, Sr. Director, Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com
Media Contact:
Josh Gitelson, Director, Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-fourth-quarter-and-fiscal-year-2022-results-may-10-2022-301519331.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.